EP3570884
HER2 mótefnasamsetning til notkunar undir húð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.1.2018EP published:
30.9.2020EP application number:
18713735.1
EP translation filed:
20.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
15.1.2038Expiry date:
15.1.2027Next due date:
31.1.2027
Title:
SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
Timeline
Today
16.1.2018EP application
30.9.2020EP Publication
20.11.2020Translation submitted
15.12.2020Registration published
15.1.2027Expires
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, South San Francisco, CA 94080, US
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
ENG-WONG, JenniferAddress:
South San Francisco,CA 94080, US
Name:
KIRSCHBROWN, WhitneyAddress:
South San Francisco,CA 94080, US
Name:
KHAN, TarikAddress:
4070 Basel, CH
Name:
LIN, JasperAddress:
South San Francisco,CA 94080, US
Name:
ALAVATTAM, SreedharaAddress:
South San Francisco,CA 94080, US
Name:
GARG, AmitAddress:
South San Francisco,CA 94080, US
Name:
HEESON, SarahAddress:
Welwyn Garden City Greater London AL7 1TW, GB
Name:
BADOVINAC-CRNJEVIC, TanjaAddress:
4070 Basel, CH
Name:
WURTH, ChristineAddress:
4070 Basel, CH
Agent
Name:
Lára Helga SveinsdóttirAddress:
Grundarstíg 23, 101, Reykjavík,
Priority
Number:
201762447359 PDate:
17.1.2017Country:
US
Classification
Categories:
A61K 39/395, A61K 9/08, A61K 47/18, A61K 47/26, A61K 47/42, C07K 16/32, A61P 35/00, A61K 38/47, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 16.12.2020
Expires: 15.1.2022
Payer: Örn Þór slf.
Number: 5
Paid: 21.12.2021
Expires: 15.1.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 16.12.2022
Expires: 15.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 20.12.2023
Expires: 15.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 27.12.2024
Expires: 15.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.1.2026
Expires: 15.1.2027
Payer: Árnason Faktor ehf.